Ocular Drug Delivery: Market Overview, Delivery Technologies, and Partnering Opportunities

It is an exciting time in the field of ocular drug delivery, with a number of innovative delivery systems showing promise.  The market is currently dominated by topical products such as drops and ointments which are inefficient and can be difficult to administer properly. Injectable formulations are available to a lesser extent and can be associated with serious side effects and require administration by a medical professional. Fortunately there are a record number of companies developing improved ocular delivery systems which provide benefits such as sustained release, accurate dosing, and ease of administration. These companies range from emerging start-ups with preclinical projects to established specialty companies with late-stage pipeline products.  Collectively, these companies have more than 70 novel ocular formulations and products in various stages of development for indications such as glaucoma, uveitis, macular degeneration, and dry eye disease.   

This 144 page report provides a comprehensive overview of the ocular drug delivery segment and includes detailed product and technology information, market data, DDS pipelines by therapeutic category, company profiles, and partnering opportunities.

Exclusive Sample Report @ https://www.reportsworldwide.com/enquiry?report_id=41318

Report Contents

Eye Diseases

• Overview and prevalence data
• Marketed therapeutics by indication

o   Age-related macular degeneration

o   Macular edema

o   Diabetic retinopathy

o   Glaucoma

 Ophthalmic Market Overview

• Sales of top ten ophthalmic products, 2015-2016
• Key players by revenue
• Key players with drug delivery-enabled products

Ocular Drug Delivery Landscape

• Non-invasive and invasive delivery technologies
• Approved ocular drug delivery formulations
• Ocular drug delivery pipeline by therapeutic category
• Future perspectives and development opportunities

Company Profiles by Technology Type

• Novel aerosol and eye drop devices
• Punctal plugs
• Topical delivery systems
• Injectables and implants
• Ocular inserts
• Drug-eluting lenses

For each company profiled, the following information is provided:

• Technology Description
  • Development Status / Pipeline Products
  • Patents and Publications
  • Partnership Opportunities
  • Business Development & Licensing Contact

Sample of Companies Profiled:

• Aciont
• Envisia Therapeutics
• EyeGate Pharma
• Graybug Vision
• iVeena
• Kala Pharmaceuticals
• KMG Pharma
• Leo Lens Technology
• Mati Therapeutics
• Ocular Therapeutix
• Oculis Pharma
• pSivida
• Spindrift Therapeutics
• ViSci, Ltd.

Reasons to Buy:

• Identify enabling delivery systems or devices for pipeline drugs
• Scout technologies for life cycle management of commercialized ophthalmic drugs
• Understand the key players and therapeutic segments
• Obtain product and technology information for launched ophthalmics
• View pipeline details for novel ocular formulations in development
• Discover product and technology licensing opportunities

TABLE OF CONTENTS

Introduction

Chapter I: Eye Diseases

Age Related Macular Degeneration (AMD)

Macular Edema and Diabetic Retinopathy

Glaucoma

Inflammatory Conditions

Chapter II: Market Overview

Key Players

Chapter III: Ophthalmic Drug Delivery Landscape

Non-Invasive Delivery Technologies

Invasive Delivery Technologies

Approved Ocular DDS Products

Ocular DDS Pipeline

Development Opportunities

Future Perspectives

 TOC Continued……!

Ask to Expertise @ https://www.reportsworldwide.com/enquiry?report_id=41318

About US:

Reportsworldwide.com is a one stop shop for all market intelligence needs. Our database of market research reports provides in depth coverage of 12 top industry verticals worldwide. We help you meet your market intelligence needs by mapping it with our database of market research reports including.

Contact Us:

Email: sales@reportsworldwide.com

Phone: +1 (617) 398-1947